New DNA tests could spot hidden chromosome flaws in infertility and developmental disorders

NCT ID NCT05290051

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two new technologies—optical genome mapping and long-read DNA sequencing—against standard chromosome tests in 350 people with infertility, intellectual disability, birth defects, or miscarriage. The goal was to see if these newer methods can find more chromosome abnormalities than current approaches. Results could lead to a single, more powerful test for genetic diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Optical genome mapping and long-read DNA sequencing
What this could lead to
If successful, these new tests could replace current methods and find more chromosome abnormalities, leading to better diagnoses for infertility, developmental disorders, and recurrent miscarriages.
What could go wrong
This is an early comparison study, not a treatment trial. The new tests may not be more accurate or practical than existing ones, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Abortion, Spontaneous Congenital Abnormalities infertility disorder intellectual disability

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cochin APHP

    Paris, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.